Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis

Ryan H. Moy, Austin P. Huffman, Lee P. Richman, Lisa Crisalli, Ximi K. Wang, James A. Hoxie, Rosemarie Mick, Stephen G. Emerson, Yi Zhang, Robert H. Vonderheide, David L. Porter, Ran Reshef

Blood (2017) 129 (7): 906–916.

https://doi.org/10.1182/blood-2016-08-735076

Published: 2017

Includes: Supplemental data

Journal Articles

Immunologic Effects of CCR5 Blockade in Graft-Versus-Host Disease Prophylaxis

Ryan H Moy, MD PhD, Austin P Huffman, BA, Lee P Richman, BA, Lisa Crisalli, BS, James A Hoxie, MD, Robert H Vonderheide, MD DPhil, David L Porter, MD, Ran Reshef, MD

Blood (2015) 126 (23): 920.

https://doi.org/10.1182/blood.V126.23.920.920

Published: 2015

Journal Articles

NKG2D expression by CD8 + T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT

Mobin A. Karimi, Jerrod L. Bryson, Lee P. Richman, Andrew D. Fesnak, Theresa M. Leichner, Atsushi Satake, Robert H. Vonderheide, David H. Raulet, Ran Reshef, Taku Kambayashi

Blood (2015) 125 (23): 3655–3663.

https://doi.org/10.1182/blood-2015-02-629006

Published: 2015

Includes: Supplemental data

Journal Articles

CD8 Cell Dose in Peripheral Blood Stem-Cell Grafts Correlates with Relapse and Survival after Reduced Intensity Allogeneic Stem-Cell Transplantation

Ran Reshef, MD, Austin P. Huffman, BA, Amy Gao, BA, Mary Sell, BS MT(ASCP), Marlise R. Luskin, MD, Selina M. Luger, MD, Alison Wakoff Loren, MDMS, Elizabeth O. Hexner, MD, Sunita Dwivedy Nasta, MD, Noelle V. Frey, MDMS, Saar I. Gill, MD PhD, James Mangan, MD PhD, Lee P. Richman, BA, Taku Kambayashi, MDPhD, Edward A. Stadtmauer, MD, Robert H. Vonderheide, MDDPhil, David L. Porter, MD

Blood (2014) 124 (21): 1260.

https://doi.org/10.1182/blood.V124.21.1260.1260

Published: 2014

Journal Articles

Extended CCR5 Blockade in Graft-Versus-Host Disease Prophylaxis – a Phase II Study

Ran Reshef, MD, James K. Mangan, MDPhD, Selina M. Luger, MD, Alison Wakoff Loren, MDMS, Elizabeth O. Hexner, MD, Noelle V. Frey, MDMS, Edward A. Stadtmauer, MD, Robin E. Blauser, BSN RN, Lee P. Richman, BA, Austin P. Huffman, BA, Alex Ganetsky, PharmD, Edward P. Acosta, PharmD, James A. Hoxie, MD, Rosemarie Mick, MS, Robert H. Vonderheide, MDDPhil, David L. Porter, MD

Blood (2014) 124 (21): 2491.

https://doi.org/10.1182/blood.V124.21.2491.2491

Published: 2014

Journal Articles

Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation

Blood (2012) 119 (12): 2956–2959.

https://doi.org/10.1182/blood-2011-09-378398

Published: 2012

Includes: Supplemental data

Journal Articles

Inhibition of Lymphocyte Trafficking Using a CCR5 Antagonist – Final Results of a Phase I/II Study

Ran Reshef, MD, Selina M. Luger, MD, Elizabeth O. Hexner, MD, Alison W. Loren, MD, Noelle V. Frey, MD, Steven C. Goldstein, MD, Sunita D. Nasta, MD, Edward A. Stadtmauer, MD, Jacqueline Smith, CRNP, Rosemarie Mick, MS, Daniel F. Heitjan, PhD, James A. Hoxie, MD, Stephen G. Emerson, MD, PhD, Robert H. Vonderheide, MD, PhD, David L. Porter, MD

Blood (2011) 118 (21): 1011.

https://doi.org/10.1182/blood.V118.21.1011.1011

Published: 2011

Journal Articles

Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma

Blood (2011) 117 (3): 788–797.

https://doi.org/10.1182/blood-2010-08-299396

Published: 2011

Includes: Supplemental data

Journal Articles

Transfer of influenza vaccine–primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial

Edward A. Stadtmauer, Dan T. Vogl, Eline Luning Prak, Jean Boyer, Nicole A. Aqui, Aaron P. Rapoport, Kenyetta R. McDonald, Xiaoling Hou, Heather Murphy, Rita Bhagat, Patricia A. Mangan, Anne Chew, Elizabeth A. Veloso, Bruce L. Levine, Robert H. Vonderheide, Abbas F. Jawad, Carl H. June, Kathleen E. Sullivan

Blood (2011) 117 (1): 63–71.

https://doi.org/10.1182/blood-2010-07-296822

Published: 2011

Journal Articles

Prevention of Graft-Versus-Host Disease by Inhibition of Lymphocyte Trafficking Using a CCR5 Antagonist

Ran Reshef, MD, Selina M. Luger, MD, Alison W. Loren, MD, Noelle V. Frey, MD, Steven C. Goldstein, MD, Elizabeth O. Hexner, MD, Edward A. Stadtmauer, MD, Jacqueline Smith, CRNP, Rosemarie Mick, MS, Daniel F. Heitjan, PhD, Susan E. Shetzline, PhD, Gwenn-ael H. Danet-Desnoyers, PhD, Stephen G. Emerson, MD, PhD, James A. Hoxie, MD, Robert H. Vonderheide, MD, PhD, David L. Porter, MD

Blood (2010) 116 (21): 673.

https://doi.org/10.1182/blood.V116.21.673.673

Published: 2010

Journal Articles

Schedule Dependent Effects of Adoptively Transferred Autologous T Cells After AutoSCT for Myeloma: Accelerated Immune Recovery Is Associated with Improved Event-Free Survival.

Blood (2009) 114 (22): 784.

https://doi.org/10.1182/blood.V114.22.784.784

Published: 2009

Journal Articles

Influenza (flu) Vaccine Administration to Patients with Multiple Myeloma (MM) Prior to Autologous T-Cell Harvest Leads to Better Reconstitution of Flu Immunity After High Dose Melphalan and Autologous Stem Cell Transplant (ASCT) and Reinfusion of Primed Ex-Vivo Co-Stimulated Autologous T-Cells and Post-ASCT Second Flu Vaccination Than Post-ASCT Flu Vaccination Alone.

Edward A. Stadtmauer, MD, Dan T. Vogl, MD, Nicole A. Aqui, MD, Aaron P. Rapoport, MD, Kenyetta Macdonald, Heather Murphy, Rita Bhagat, RN, Patricia A. Mangan, APRN, BC, Anne Chew, PhD, Elizabeth Veloso, RN, JD, Bruce Levine, PhD, Robert H. Vonderheide, MD, DPhil, Carl H. June, MD, Kathleen Sullivan, MD

Blood (2009) 114 (22): 797.

https://doi.org/10.1182/blood.V114.22.797.797

Published: 2009

Journal Articles

Rapid T Cell Recovery and Possible Auto-GVHD Following Adoptive Transfer of Ex-Vivo Costimulated Autologous T Cells at Day +2 Post-Transplant.

Aaron P. Rapoport, MD, Stephan A. Grupp, MD, PhD, Edward A. Stadtmauer, MD, Robert H. Vonderheide, MD, PhD, Bruce L. Levine, PhD, Hongbin Fang, PhD, Kelly Yager, RN, Anne Chew, PhD, Elizabeth Veloso, RN, Carl H. June, MD

Blood (2007) 110 (11): 769.

https://doi.org/10.1182/blood.V110.11.769.769

Published: 2007

Journal Articles

Host Immune Responses Against CT Antigens in Multiple Myeloma Patients.

Nikoletta Lendvai, MD, PhD, Sacha Gnjatic, PhD, Erika Ritter, Yao-Tseng Chen, MD, PhD, Christina Coughlin, MD, PhD, Robert H. Vonderheide, MD, DPhil, Ruben Niesvizky, MD, Nina Bhardwaj, MD, PhD, Selina Chen-Kiang, PhD, Lloyd J. Old, MD, Hearn J. Cho, MD, PhD

Blood (2006) 108 (11): 3492.

https://doi.org/10.1182/blood.V108.11.3492.3492

Published: 2006

Journal Articles

RNA-transfected CD40-activated B cells induce functional T-cell responses against viral and tumor antigen targets: implications for pediatric immunotherapy

Christina M. Coughlin, Barbara A. Vance, Stephan A. Grupp, Robert H. Vonderheide

Blood (2004) 103 (6): 2046–2054.

https://doi.org/10.1182/blood-2003-07-2379

Published: 2004

Journal Articles

The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cells

Britta Maecker, David H. Sherr, Robert H. Vonderheide, Michael S. von Bergwelt-Baildon, Naoto Hirano, Karen S. Anderson, Zhinan Xia, Marcus O. Butler, Kai W. Wucherpfennig, Carl O'Hara, Geoffrey Cole, Silvia S. Kwak, Urban Ramstedt, Andy J. Tomlinson, Roman M. Chicz, Lee M. Nadler, Joachim L. Schultze

Blood (2003) 102 (9): 3287–3294.

https://doi.org/10.1182/blood-2003-05-1374

Published: 2003

Journal Articles

Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34 + -selected hematopoietic cell transplantation

Ginna G. Laport, Bruce L. Levine, Edward A. Stadtmauer, Stephen J. Schuster, Selina M. Luger, Stephan Grupp, Nancy Bunin, Frank J. Strobl, Julio Cotte, Zhaohui Zheng, Brian Gregson, Patricia Rivers, Robert H. Vonderheide, David N. Liebowitz, David L. Porter, Carl H. June

Blood (2003) 102 (6): 2004–2013.

https://doi.org/10.1182/blood-2003-01-0095

Published: 2003

Journal Articles

Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application

Michael S. von Bergwelt-Baildon, Robert H. Vonderheide, Britta Maecker, Naoto Hirano, Karen S. Anderson, Marcus O. Butler, Zhinan Xia, Wan Y. Zeng, Kai W. Wucherpfennig, Lee M. Nadler, Joachim L. Schultze

Blood (2002) 99 (9): 3319–3325.

https://doi.org/10.1182/blood.V99.9.3319

Published: 2002

NARROW

Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis

Immunologic Effects of CCR5 Blockade in Graft-Versus-Host Disease Prophylaxis

NKG2D expression by CD8 + T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT

CD8 Cell Dose in Peripheral Blood Stem-Cell Grafts Correlates with Relapse and Survival after Reduced Intensity Allogeneic Stem-Cell Transplantation

Extended CCR5 Blockade in Graft-Versus-Host Disease Prophylaxis – a Phase II Study

Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation

Inhibition of Lymphocyte Trafficking Using a CCR5 Antagonist – Final Results of a Phase I/II Study

Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma

Transfer of influenza vaccine–primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial

Prevention of Graft-Versus-Host Disease by Inhibition of Lymphocyte Trafficking Using a CCR5 Antagonist

Schedule Dependent Effects of Adoptively Transferred Autologous T Cells After AutoSCT for Myeloma: Accelerated Immune Recovery Is Associated with Improved Event-Free Survival.

Rapid T Cell Recovery and Possible Auto-GVHD Following Adoptive Transfer of Ex-Vivo Costimulated Autologous T Cells at Day +2 Post-Transplant.

Host Immune Responses Against CT Antigens in Multiple Myeloma Patients.

RNA-transfected CD40-activated B cells induce functional T-cell responses against viral and tumor antigen targets: implications for pediatric immunotherapy

The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cells

Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34 + -selected hematopoietic cell transplantation

Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only